OA11.05 Results of a Phase III Trial of Prolgolimab with Chemotherapy as First-Line Therapy for Patients with Advanced Non-Squamous NSCLC: DOMAJOR
Laktionov, K., Smolin, A., Stroyakovsky, D., Moiseenko, V., Dvorkin, M., Andabekov, T., Cheng, Y., Liu, B., Kozlov, V., Odintsova, S., Dvoretsky, S., Mochalova, A., Urda, M., Yi, T., Li, X., László, U., Müller, V., Bogos, K., Fadeeva, N., Musaev, G., Liu, Q., Kirtbaya, D., Shi, J., Gladkov, O., Narimanov, M., Semiglazova, T., Khasanova, A., Chovanec, J., Andrašina, I., Szabová, A., Rosinská, O., Sudekova, D., Zsolt, P.-S., Ran, F., Sun, M., Jiang, O., Chen, R., Zhao, E., Liu, C., Tan, W., Pirmagomedov, A., Poddubskaya, E., Kislov, N., Shumskaya, I., Zinkina-Orikhan, A., Linkova, Y., Liaptseva, D., Siljutina, A., Sorokina, I., Kriukov, F.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article